Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 49372L209 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (4) | ||||
|
Stonepine Capital Management, LLC
13G/A
|
2.1% |
2/13/2026
Event 12/31/2025
|
||
| Stonepine Capital Management, LLC | 2.1% | |||
| Stonepine Capital, L.P. | 2.1% | |||
| Stonepine GP, LLC | 2.1% | |||
| Jon M. Plexico | 2.1% | |||
|
Avidity Partners Management LP
13G/A
|
0% |
11/14/2025
Event 9/30/2025
|
||
| Avidity Partners Management LP | 0% | |||
| Avidity Partners Management (GP) LLC | 0% | |||
| Avidity Capital Partners Fund (GP) LP | 0% | |||
| Avidity Capital Partners (GP) LLC | 0% | |||
| Avidity Master Fund LP | 0% | |||
| Michael Gregory | 0% | |||
|
Baselake Partners, LP
13G/A
|
0% |
5/28/2026
Event 5/11/2026
|
||
| Baselake Partners, LP | 0% | |||
| Baselake Management, LLC | 0% | |||
| David Paolella | 0% | |||
|
Tang Capital Management LLC
13D/A
|
0% |
5/13/2026
Event 5/11/2026
|
||
| Tang Capital Management, LLC | 0% | |||
| Kevin Tang | 0% | |||
| Tang Capital Partners, LP | 0% | |||
| Tang Capital Partners International, LP | 0% | |||
| Tang Capital Partners III, Inc | 0% | |||
| Tang Capital Partners IV, Inc | 0% | |||
| Concentra Biosciences, LLC | 0% | |||